CS
Candriam SCA Portfolio holdings
AUM
$17.3B
1-Year Return
21.68%
This Quarter Return
+16.29%
1 Year Return
+21.68%
3 Year Return
+102.54%
5 Year Return
+176.54%
10 Year Return
+489.52%
AUM
$7.82B
AUM Growth
+$1.31B
(+20%)
Cap. Flow
+$157M
Cap. Flow
% of AUM
2.01%
Top 10 Holdings %
Top 10 Hldgs %
19.27%
Holding
875
New
65
Increased
350
Reduced
240
Closed
80
Top Buys
| 1 |
Merck
MRK
|
$46.7M |
| 2 |
Bristol-Myers Squibb
BMY
|
$29.1M |
| 3 |
Gilead Sciences
GILD
|
$27.9M |
| 4 |
BZUN
Baozun
BZUN
|
$26.6M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
$26.5M |
Top Sells
| 1 |
CELG
Celgene Corp
CELG
|
$81.1M |
| 2 |
Danaher
DHR
|
$31.9M |
| 3 |
LOXO
Loxo Oncology, Inc
LOXO
|
$28.1M |
| 4 |
Agilent Technologies
A
|
$28M |
| 5 |
McCormick & Company Non-Voting
MKC
|
$20.1M |
Sector Composition
| 1 | Healthcare | 33.36% |
| 2 | Technology | 16% |
| 3 | Financials | 11.25% |
| 4 | Consumer Discretionary | 8.98% |
| 5 | Communication Services | 7.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
151
Tesla
TSLA
$1.13T
| $12.5M | 0.16% |
671,625
+26,940
| +4% | +$503K |
|
152
General Mills
GIS
$27B
| $12.5M | 0.16% |
241,215
+67,709
| +39% | +$3.5M |
|
153
Consolidated Edison
ED
$35.4B
| $12.4M | 0.16% |
145,846
+13,122
| +10% | +$1.11M |
|
154
Nike
NKE
$109B
| $12.2M | 0.16% |
144,831
-248
| -0.2% | -$20.9K |
|
155
Kimberly-Clark
KMB
$43.1B
| $12.1M | 0.15% |
97,252
+59,985
| +161% | +$7.43M |
|
156
MacroGenics
MGNX
$126M
| $12M | 0.15% |
665,488
+122,501
| +23% | +$2.2M |
|
157
Capital One
COF
$142B
| $12M | 0.15% |
146,466
+2,978
| +2% | +$243K |
|
158
Comerica
CMA
$8.85B
| $11.8M | 0.15% |
161,433
+78,920
| +96% | +$5.79M |
|
|
BOLD
159
DELISTED
Audentes Therapeutics, Inc
BOLD
| $11.7M | 0.15% |
300,800
| – | – |
|
160
Pinduoduo
PDD
$177B
| $11.6M | 0.15% |
+469,600
| New | +$11.6M |
|
161
Deere & Co
DE
$128B
| $11.5M | 0.15% |
72,227
-10,533
| -13% | -$1.68M |
|
162
HCA Healthcare
HCA
$98.5B
| $11.5M | 0.15% |
87,933
-85,013
| -49% | -$11.1M |
|
163
Toronto Dominion Bank
TD
$127B
| $11.4M | 0.15% |
210,843
+11,874
| +6% | +$645K |
|
|
164
McCormick & Company Non-Voting
MKC
$19B
| $11.4M | 0.15% |
151,890
-266,542
| -64% | -$20.1M |
|
165
Ameriprise Financial
AMP
$46.1B
| $11.3M | 0.15% |
78,464
-3,012
| -4% | -$435K |
|
166
Exelon
EXC
$43.9B
| $11.2M | 0.14% |
314,237
+162,493
| +107% | +$5.81M |
|
|
XLRN
167
DELISTED
Acceleron Pharma Inc.
XLRN
| $11.2M | 0.14% |
240,500
-2,258
| -0.9% | -$105K |
|
168
Dentsply Sirona
XRAY
$2.92B
| $11.2M | 0.14% |
225,732
+86,970
| +63% | +$4.31M |
|
169
Carnival Corp
CCL
$42.8B
| $11.2M | 0.14% |
220,426
-14,251
| -6% | -$723K |
|
|
SPPI
170
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
| $11.2M | 0.14% |
1,044,900
+65,075
| +7% | +$696K |
|
171
Caterpillar
CAT
$198B
| $11M | 0.14% |
81,247
+3,531
| +5% | +$478K |
|
172
Boeing
BA
$174B
| $10.9M | 0.14% |
28,673
-141
| -0.5% | -$53.8K |
|
173
Karyopharm Therapeutics
KPTI
$57.2M
| $10.9M | 0.14% |
124,452
+4,949
| +4% | +$434K |
|
174
Arrowhead Research
ARWR
$4.02B
| $10.9M | 0.14% |
594,000
| – | – |
|
175
D.R. Horton
DHI
$54.2B
| $10.9M | 0.14% |
262,379
-16,883
| -6% | -$699K |
|